ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 70 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 315 | -97.5% | 0.00% | – |
Q2 2023 | $4,000 | -20.0% | 12,610 | +16.4% | 0.00% | – |
Q1 2023 | $5,000 | – | 10,831 | +5315.5% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 200 | -91.2% | 0.00% | – |
Q3 2022 | $2,000 | -75.0% | 2,268 | -42.2% | 0.00% | – |
Q1 2022 | $8,000 | -11.1% | 3,925 | +80.9% | 0.00% | – |
Q3 2021 | $9,000 | -69.0% | 2,170 | -60.7% | 0.00% | – |
Q2 2021 | $29,000 | -56.1% | 5,523 | -61.2% | 0.00% | – |
Q1 2021 | $66,000 | +3200.0% | 14,229 | +2745.8% | 0.00% | – |
Q4 2020 | $2,000 | -98.5% | 500 | -98.8% | 0.00% | – |
Q3 2020 | $136,000 | -3.5% | 41,108 | -1.7% | 0.00% | – |
Q2 2020 | $141,000 | -35.9% | 41,809 | -27.6% | 0.00% | – |
Q1 2020 | $220,000 | -29.0% | 57,737 | +12.5% | 0.00% | – |
Q4 2019 | $310,000 | +0.6% | 51,300 | +25.7% | 0.00% | – |
Q3 2019 | $308,000 | -48.3% | 40,806 | -7.2% | 0.00% | – |
Q2 2019 | $596,000 | +172.1% | 43,976 | +8.7% | 0.00% | – |
Q1 2019 | $219,000 | +265.0% | 40,446 | +100.4% | 0.00% | – |
Q4 2018 | $60,000 | -86.3% | 20,184 | -63.8% | 0.00% | – |
Q3 2018 | $438,000 | +3269.2% | 55,819 | +4028.6% | 0.00% | – |
Q2 2018 | $13,000 | -64.9% | 1,352 | -68.9% | 0.00% | – |
Q1 2018 | $37,000 | -47.1% | 4,350 | -21.5% | 0.00% | – |
Q4 2017 | $70,000 | +191.7% | 5,540 | +91.8% | 0.00% | – |
Q3 2017 | $24,000 | +1100.0% | 2,888 | +2574.1% | 0.00% | – |
Q2 2017 | $2,000 | – | 108 | +5300.0% | 0.00% | – |
Q1 2017 | $0 | -100.0% | 2 | -98.0% | 0.00% | – |
Q4 2016 | $2,000 | +100.0% | 100 | 0.0% | 0.00% | – |
Q3 2015 | $1,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 507,191 | $5,107,000 | 0.50% |
Cormorant Asset Management, LP | 356,600 | $3,591,000 | 0.43% |
Perceptive Advisors | 558,446 | $5,623,000 | 0.42% |
NEXTHERA CAPITAL LP | 15,000 | $151,000 | 0.21% |
EMERALD ADVISERS, LLC | 237,070 | $2,387,000 | 0.11% |
AUXIER ASSET MANAGEMENT | 17,857 | $180,000 | 0.04% |
FEDERATED HERMES, INC. | 450,000 | $4,532,000 | 0.01% |
Nationwide Fund Advisors | 49,473 | $498,000 | 0.00% |
Catalyst Capital Advisors LLC | 348 | $4,000 | 0.00% |
BlackRock Institutional Trust Company, N.A. | 32,499 | $327,000 | 0.00% |